Exogenous subclinical hyperthyroidism impairs endothelial function in nodular goiter patients

Thyroid

Volumn 18, Issue 4, 2008, Pages 395-400

  Yavuz, Dilek Gogas ^a   Yazici, Dilek ^a   Toprak, Ahmet ^a   Deyneli, Oguzhan ^a   Aydin, Hasan ^a   Yüksel, Meral ^b   Akalin, Sema ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; LEVOTHYROXINE; THYROTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GOITER; HUMAN; HYPERTHYROIDISM; INSULIN SENSITIVITY; LIPID PEROXIDATION; PRIORITY JOURNAL; THYROID FUNCTION;

ADULT; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; ENDOTHELIUM; FEMALE; GOITER, NODULAR; HUMANS; HYPERTHYROIDISM; INSULIN; LIPID PEROXIDATION; MIDDLE AGED; OXIDATIVE STRESS; THYROID GLAND; THYROXINE;

EID: 42049089178     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2007.0299     Document Type: Article

References (23)

1. Ross DS 1988 Subclinical hyperthyroidism: possible danger of overzealous thyroxine replacement therapy. Mayo Clin Proc 63:1223-1229.
2. Batrinos ML 2006 The problem of exogenous subclinical hyperthyroidism. Hormones 5:119-125.
3. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC 2000 The Colorado thyroid disease prevalence Study. Arch Intern Med 160:526-534.
4. Burmeister LA, Flores A 2002 Subclinical thyrotoxicosis and the heart. Thyroid 12:495-499.
5. Shargorodsky M, Serov S, Gavish D, Leibovitz E, Harpaz D, Zimlichman R 2006 Long-term thyrotropin-suppressive therapy with levothyroxine impairs small and large artery elasticity and increases left ventricular mass in patients with thyroid carcinoma. Thyroid 16:381-386.
6. Heemstra KA, Smit JW, Eustatia-Rutten CF, Heijboer AC, Frölich M, Romijn JA, Corssmit EP 2006 Glucose tolerance and lipid profile in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial. Clin Endocrinol 65:737-744.
7. Botella-Carretero JI, Alvarez-Blasco F, Sancho J, Escobar-Morreale HF 2006 Effects of thyroid hormones on serum levels of adipokines as studied in patients with differentiated thyroid carcinoma during thyroxine withdrawal. Thyroid 16:397-402.
8. Burggraaf J, Lalezari S, Emeis JJ, Vischer UM, de Meyer PH, Pijl H, Cohen AF 2001 Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol. Thyroid 11:153-160.
9. Corretti MC, Anderson, TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R International Brachial Artery Reactivity Task Force 2002 Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. A Report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257-265.
10. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470.
11. Steinbrecher UP, Parthasaranthy S, leake D, Witztum JR, Steinberg D 2004 Modification of low-density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low-density lipoprotein phospholipids. Proc Natl Acad Sci USA 81:3883-3887.
12. Cikim AS, Oflaz H, Ozbey N, Cikim K, Umman S, Meric M, Sencer E, Molvalilar S 2004 Evaluation of endothelial function in subclinical hypothyroidism and subclinical hyperthyroidism. Thyroid 14:605-609.
13. Guang-da X, Hong-yan C, Xian-mei Z 2004 Changes in endothelium-dependent arterial dilatation before and after subtotal thyroidectomy in subjects with hyperthyroidism. Clin Endocrinol (Oxf ) 61:400-404.
14. Napoli R, Biondi B, Guardasole V, Matarazzo M, Pardo F, Angelini V, Fazio S, Sacca L 2001 Impact of hyperthyroidism and its correction on vascular reactivity in humans. Circulation 104:3076-3080.
15. Horne MK 3rd, Singh KK, Rosenfeld KG, Wesley R, Skarulis MC, Merrymam PK, Cullinane A, Costello R, Patterson A, Eggerman T, Bernstein DM, Pucino F, Csako G 2004 Is thyroid hormone suppression therapy prothrombotic? J Clin Endocrinol Metab 89:4469-4473.
16. Cetinkaya A, Kurutas EB, Buyukbese MA, Kantarceken B, Bulbuloglu E 2005 Levels of malondialdehyde and superoxide dismutase in subclinical hyperthyroidism. Mediators Inflam 24:57-59.
17. Yavuz DG, Yüksel M, Deyneli O, Ozen Y, Aydin H, Akalin S 2004 Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients. Clin Endocrinol (Oxf ) 61:515-521.
18. Videla LA, Sir T, Wolff C 1988 Increased lipid peroxidation in hyperthyroid patients: suppression by propylthiouracil treatment. Free Radic Res Commun 5:1-10.
19. Klein I, Ojamaa K 2001 Thyroid hormone and the cardiovascular system. N Engl J Med 344:501-509.
20. Volzka H, Robinson DM, Schminke U, Ludemann J, Rettig R, Felix SB, Kessler C, John U, Meng W 2004 Thyroid function and carotid wall thickness. J Clin Endocrinol Metab 89:2145-2149.
21. Dimitriadia GD, Raptis SA 2001 Thyroid hormone excess and glucose intolerance. Exp Clin Endocrinol Diabetes 109 Suppl 2:S225-S239.
22. Tene C, Zarate A, Basurto L, Islas S, Revilla C, Ochoa R, Galvan R, Santos P 2001 Correction of insulin resistance in methimazole-treated patients with Graves disease. Rev Invest Clin 53:531-535.
23. Bloch-Damti A, Bashan N 2005 Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid Redox Signal 7:1553-1567.